Together We Cure Breakthrough Fund
Our dedicated research, management, and regulatory teams are deeply committed to rapidly moving our scientific breakthroughs from the lab to the clinic and ultimately into the marketplace. This unwavering focus ensures that treating physicians across the globe gain access to new, vital tools and therapies designed to significantly enhance patient care and improve outcomes for those battling complex brain and CNS diseases.
We not only innovate with scientific rigor but also uphold the highest ethical standards in all our products, services, and communications.
Dr. Thomas Chen, the company’s founder, will transition from the CEO role to focus exclusively on his positions as Chief Medical Officer, Chief Scientific Officer, and member of the Board of Directors, ensuring his continued leadership over NeOnc’s innovative scientific strategy and clinical development.